Trade PRLD anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Prelude Therapeutics Incorporated (PRLD) is trading at US$6.26, down 1.34% today as of Aug 28, 09:52 EDT. The company has a market capitalisation of US$529.1M. Over the past 52 weeks, PRLD has traded between US$0.98 and US$6.83. On Syfe you can trade PRLD with $0 commission and add it to your watchlist.
| Previous close | US$6.34 |
|---|---|
| Market cap | US$529.1M |
| 52-week range | US$0.98 – US$6.83 |
| Volume | 364.06K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Prelude Therapeutics Incorporated
Prelude Therapeutics, Inc. is a clinical-stage oncology company, which engages in the development of novel precision cancer medicines. It also focuses on the design and development of small molecule agents for cancer medicines. The company was founded by Krishna Vaddi in 2016 and is headquartered in Wilmington, DE.
Year: 2020
Prelude Therapeutics Prices $90 Million Underwritten Offering
Apr 20, 11:09 AM · MT Newswires
Prelude Therapeutics Incorporated (PRLD) stock is trading at US$6.26, -1.34% from the previous close of US$6.34.
The market cap for Prelude Therapeutics Incorporated (PRLD) stock is approximately US$529.1M.
The 52-week high for Prelude Therapeutics Incorporated (PRLD) stock is US$6.83.
The 52-week low for Prelude Therapeutics Incorporated (PRLD) stock is US$0.98.
Prelude Therapeutics Incorporated (PRLD) does not currently pay a dividend.
Stay on top of PRLD
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
